Caty Carrera, Jara Cárcel-Márquez, Natalia Cullell, Nuria Torres-Águila, Elena Muiño, José Castillo, Tomás Sobrino, Francisco Campos, Emilio Rodríguez-Castro, Laia Llucià-Carol, Mònica Millán, Lucía Muñoz-Narbona, Elena López-Cancio, Alejandro Bustamante, Marc Ribó, José Álvarez-Sabín, Jordi Jiménez-Conde, Jaume Roquer, Eva Giralt-Steinhauer, Carolina Soriano-Tárraga, Marina Mola-Caminal, Cristófol Vives-Bauza, Rosa Díaz Navarro, Silvia Tur, Victor Obach, Juan Francisco Arenillas, Tomás Segura, Gemma Serrano-Heras, Joan Martí-Fàbregas, Raquel Delgado-Mederos, M Mar Freijo-Guerrero, Francisco Moniche, Juan Antonio Cabezas, Mar Castellanos, Cristina Gallego-Fabrega, Jonathan González-Sanchez, Jurek Krupinsky, Daniel Strbian, Turgut Tatlisumak, Vincent Thijs, Robin Lemmens, Agnieszka Slowik, Johanna Pera, Steven Kittner, John Cole, Laura Heitsch, Laura Ibañez, Carlos Cruchaga, Jin-Moo Lee, Joan Montaner, Israel Fernández-Cadenas
Haemorrhagic transformation is a complication of recombinant tissue-plasminogen activator treatment. The most severe form, parenchymal haematoma, can result in neurological deterioration, disability, and death. Our objective was to identify single nucleotide variations associated with a risk of parenchymal haematoma following thrombolytic therapy in patients with acute ischaemic stroke. A fixed-effect genome-wide meta-analysis was performed combining two-stage genome-wide association studies (n = 1904)...
September 4, 2021: Brain